Skip to main content
Top
Published in: BMC Infectious Diseases 1/2015

Open Access 01-12-2015 | Research article

Evaluation of HIV testing algorithms in Ethiopia: the role of the tie-breaker algorithm and weakly reacting test lines in contributing to a high rate of false positive HIV diagnoses

Authors: Leslie Shanks, M Ruby Siddiqui, Jarmila Kliescikova, Neil Pearce, Cono Ariti, Libsework Muluneh, Erwan Pirou, Koert Ritmeijer, Johnson Masiga, Almaz Abebe

Published in: BMC Infectious Diseases | Issue 1/2015

Login to get access

Abstract

Background

In Ethiopia a tiebreaker algorithm using 3 rapid diagnostic tests (RDTs) in series is used to diagnose HIV. Discordant results between the first 2 RDTs are resolved by a third ‘tiebreaker’ RDT. Médecins Sans Frontières uses an alternate serial algorithm of 2 RDTs followed by a confirmation test for all double positive RDT results. The primary objective was to compare the performance of the tiebreaker algorithm with a serial algorithm, and to evaluate the addition of a confirmation test to both algorithms. A secondary objective looked at the positive predictive value (PPV) of weakly reactive test lines.

Methods

The study was conducted in two HIV testing sites in Ethiopia. Study participants were recruited sequentially until 200 positive samples were reached. Each sample was re-tested in the laboratory on the 3 RDTs and on a simple to use confirmation test, the Orgenics Immunocomb Combfirm® (OIC). The gold standard test was the Western Blot, with indeterminate results resolved by PCR testing.

Results

2620 subjects were included with a HIV prevalence of 7.7%. Each of the 3 RDTs had an individual specificity of at least 99%. The serial algorithm with 2 RDTs had a single false positive result (1 out of 204) to give a PPV of 99.5% (95% CI 97.3%-100%). The tiebreaker algorithm resulted in 16 false positive results (PPV 92.7%, 95% CI: 88.4%-95.8%). Adding the OIC confirmation test to either algorithm eliminated the false positives. All the false positives had at least one weakly reactive test line in the algorithm. The PPV of weakly reacting RDTs was significantly lower than those with strongly positive test lines.

Conclusion

The risk of false positive HIV diagnosis in a tiebreaker algorithm is significant. We recommend abandoning the tie-breaker algorithm in favour of WHO recommended serial or parallel algorithms, interpreting weakly reactive test lines as indeterminate results requiring further testing except in the setting of blood transfusion, and most importantly, adding a confirmation test to the RDT algorithm. It is now time to focus research efforts on how best to translate this knowledge into practice at the field level.

Trial registration

Clinical Trial registration #: NCT01716299
Literature
3.
go back to reference World Health Organization. Service delivery approaches to HIV testing and Counselling (HTC). Geneva: WHO; 2012. World Health Organization. Service delivery approaches to HIV testing and Counselling (HTC). Geneva: WHO; 2012.
4.
go back to reference Gray RH, Makumbi F, Serwadda D, Lutalo T, Nalugoda F, Opendi P, et al. Limitations of rapid HIV-1 tests during screening for trials in Uganda: diagnostic test accuracy study. BMJ. 2007;335(7612):188.CrossRefPubMedPubMedCentral Gray RH, Makumbi F, Serwadda D, Lutalo T, Nalugoda F, Opendi P, et al. Limitations of rapid HIV-1 tests during screening for trials in Uganda: diagnostic test accuracy study. BMJ. 2007;335(7612):188.CrossRefPubMedPubMedCentral
5.
go back to reference Klarkowski DB, Wazome JM, Lokuge KM, Shanks L, Mills CF, O’Brien DP. The Evaluation of a rapid In situ HIV confirmation test in a programme with a high failure rate of the WHO HIV two-test diagnostic algorithm. PloSOne. 2009;4(2):e4351.CrossRef Klarkowski DB, Wazome JM, Lokuge KM, Shanks L, Mills CF, O’Brien DP. The Evaluation of a rapid In situ HIV confirmation test in a programme with a high failure rate of the WHO HIV two-test diagnostic algorithm. PloSOne. 2009;4(2):e4351.CrossRef
6.
go back to reference Singer DE, Kiwanuka N, Serwadda D, Nalugoda F, Hird L, Bulken-Hoover J, et al. Use of stored serum from Uganda for development and evaluation of a human immunodeficiency virus type 1 testing algorithm involving multiple rapid immunoassays. J Clin Microbiol. 2005;43(10):5312–5.CrossRefPubMedPubMedCentral Singer DE, Kiwanuka N, Serwadda D, Nalugoda F, Hird L, Bulken-Hoover J, et al. Use of stored serum from Uganda for development and evaluation of a human immunodeficiency virus type 1 testing algorithm involving multiple rapid immunoassays. J Clin Microbiol. 2005;43(10):5312–5.CrossRefPubMedPubMedCentral
7.
go back to reference Zeh C, Oyaro B, Vandenhoudt H, Amornhul P, Kasembeli A, Bondo P, et al. Performance of six commercial enzyme immunoassays and two alternative HIV-testing algorithms for the diagnosis of HIV-1 infection in Kisumu. Western Kenya J Virol Methods. 2011;176(1–2):24–31.CrossRefPubMed Zeh C, Oyaro B, Vandenhoudt H, Amornhul P, Kasembeli A, Bondo P, et al. Performance of six commercial enzyme immunoassays and two alternative HIV-testing algorithms for the diagnosis of HIV-1 infection in Kisumu. Western Kenya J Virol Methods. 2011;176(1–2):24–31.CrossRefPubMed
8.
go back to reference Galiwango RM, Musoke R, Lubyayi L, Ssekubugu R, Kalibbala S, Ssekweyama V, et al. Evaluation of current rapid HIV test algorithms in Rakai. Uganda J Virol Meth. 2013;192:25–7.CrossRef Galiwango RM, Musoke R, Lubyayi L, Ssekubugu R, Kalibbala S, Ssekweyama V, et al. Evaluation of current rapid HIV test algorithms in Rakai. Uganda J Virol Meth. 2013;192:25–7.CrossRef
9.
go back to reference Klarkowski D, Glass K, O’Brien DP, Lokuge K, Piriou E, Shanks L. Variation in specificity of HIV rapid diagnostic tests over place and time: an analysis of discordancy data using a bayesian approach. PLoS ONE. 2013;8(11):e81656. doi:10.1371/journal.pone.0081656.CrossRefPubMedPubMedCentral Klarkowski D, Glass K, O’Brien DP, Lokuge K, Piriou E, Shanks L. Variation in specificity of HIV rapid diagnostic tests over place and time: an analysis of discordancy data using a bayesian approach. PLoS ONE. 2013;8(11):e81656. doi:10.1371/journal.pone.0081656.CrossRefPubMedPubMedCentral
10.
go back to reference Anzala O, Sanders EJ, Kamali A, Katende M, Mutua GN, Ruzagira E, et al. Sensitivity and specificity of HIV rapid tests used for research and voluntary counselling and testing. East Afri Med J. 2008;85(10):500–4. Anzala O, Sanders EJ, Kamali A, Katende M, Mutua GN, Ruzagira E, et al. Sensitivity and specificity of HIV rapid tests used for research and voluntary counselling and testing. East Afri Med J. 2008;85(10):500–4.
11.
go back to reference Kroidl I, Clowes P, Mwalongo W, Maganga L, Maboko L, Kroidl A, et al. Low specificity of Determine HIV1/2 RDT using whole blood in south west Tanzania. PLoS One. 2012;7(6):e39529.CrossRefPubMedPubMedCentral Kroidl I, Clowes P, Mwalongo W, Maganga L, Maboko L, Kroidl A, et al. Low specificity of Determine HIV1/2 RDT using whole blood in south west Tanzania. PLoS One. 2012;7(6):e39529.CrossRefPubMedPubMedCentral
12.
go back to reference Kagulire SC, Opendi P, Stamper PD, Nakavuma JL, Mills LA, Makumbi F, et al. Field evaluation of five rapid diagnostic tests for screening of HIV-1 infections in rural Rakai. Uganda Int J STD AIDS. 2011;22(6):308–9.CrossRefPubMed Kagulire SC, Opendi P, Stamper PD, Nakavuma JL, Mills LA, Makumbi F, et al. Field evaluation of five rapid diagnostic tests for screening of HIV-1 infections in rural Rakai. Uganda Int J STD AIDS. 2011;22(6):308–9.CrossRefPubMed
13.
go back to reference Sacks R, Omodele-Lucien A, Whitbread N, Muir D, Smith A. Rapid HIV testing using Determine™ HIV 1/2 antibody tests: is there a difference between the visual appearance of true- and false-positive tests? Int J STD AIDS September. 2012;23(9):644–6.CrossRef Sacks R, Omodele-Lucien A, Whitbread N, Muir D, Smith A. Rapid HIV testing using Determine™ HIV 1/2 antibody tests: is there a difference between the visual appearance of true- and false-positive tests? Int J STD AIDS September. 2012;23(9):644–6.CrossRef
14.
go back to reference Shanks L, Klarkowski D, O’Brien DP. False positive HIV diagnoses in resource limited settings: operational lessons learned for HIV programmes. PLoS One. 2013;8:e59906. doi:10.1371/journal.pone.0059906.CrossRefPubMedPubMedCentral Shanks L, Klarkowski D, O’Brien DP. False positive HIV diagnoses in resource limited settings: operational lessons learned for HIV programmes. PLoS One. 2013;8:e59906. doi:10.1371/journal.pone.0059906.CrossRefPubMedPubMedCentral
15.
go back to reference Department of Health and Human Services/Centre for Disease Control and Prevention. Guidelines for Appropriate Evaluations of HIV Testing Technologies in Africa. 2002 Department of Health and Human Services/Centre for Disease Control and Prevention. Guidelines for Appropriate Evaluations of HIV Testing Technologies in Africa. 2002
16.
go back to reference Agence Nationale d’Accréditation et d’Evaluation en Santé. Stratégies du diagnostic biologique de l’infection due au VIH chez les sujets ages de plus de 18 mois (à l’exclusion du dépistage sur les dons de sang et chez les donneurs d’organes ou de tissus). 2000 Agence Nationale d’Accréditation et d’Evaluation en Santé. Stratégies du diagnostic biologique de l’infection due au VIH chez les sujets ages de plus de 18 mois (à l’exclusion du dépistage sur les dons de sang et chez les donneurs d’organes ou de tissus). 2000
17.
go back to reference Sandler SG, Dodd RY, Fang CT. Diagnostic tests for HIV infection: Serology. In: De Vita VT, Hellman S, Rosenberg SA, editors. AIDS: etiology, treatment, and prevention. 2nd ed. Philadelphia: J.B. Lippincott; 1988. p. 121–6. Sandler SG, Dodd RY, Fang CT. Diagnostic tests for HIV infection: Serology. In: De Vita VT, Hellman S, Rosenberg SA, editors. AIDS: etiology, treatment, and prevention. 2nd ed. Philadelphia: J.B. Lippincott; 1988. p. 121–6.
18.
go back to reference Leisenring W, Alonzo T, Pepe MS. Comparisons of predictive values of binary medical diagnostic tests for paired designs. Biometrics. 2000;56(2):345–51.CrossRefPubMed Leisenring W, Alonzo T, Pepe MS. Comparisons of predictive values of binary medical diagnostic tests for paired designs. Biometrics. 2000;56(2):345–51.CrossRefPubMed
19.
go back to reference Baveewo S, Kamya MR, Mayanja-Kizza H, Fatch R, Bangsberg DR, Coates T, et al. Potential for false positive HIV test results with the serial rapid HIV testing algorithm. BMC Res Notes. 2012;5:154.CrossRefPubMedPubMedCentral Baveewo S, Kamya MR, Mayanja-Kizza H, Fatch R, Bangsberg DR, Coates T, et al. Potential for false positive HIV test results with the serial rapid HIV testing algorithm. BMC Res Notes. 2012;5:154.CrossRefPubMedPubMedCentral
20.
go back to reference Boeras D, Luisi N, Karita E, McKinney S, Sharkey T, Keeling M, et al. Indeterminate and discrepant rapid HIV test results in couples’ HIV testing and counselling centres in Africa. J Int AIDS Soc. 2011;14:18.CrossRefPubMedPubMedCentral Boeras D, Luisi N, Karita E, McKinney S, Sharkey T, Keeling M, et al. Indeterminate and discrepant rapid HIV test results in couples’ HIV testing and counselling centres in Africa. J Int AIDS Soc. 2011;14:18.CrossRefPubMedPubMedCentral
21.
go back to reference Meles H, Wolday D, Fontanet A, Tsegaye A, Tilahun T, Aklilu M, et al. Indeterminate human immunodeficiency virus Western blot profiles in Ethiopians with discordant screening-assay results. Clin Diagn Lab Immunol. 2002;9(1):160–3.PubMedPubMedCentral Meles H, Wolday D, Fontanet A, Tsegaye A, Tilahun T, Aklilu M, et al. Indeterminate human immunodeficiency virus Western blot profiles in Ethiopians with discordant screening-assay results. Clin Diagn Lab Immunol. 2002;9(1):160–3.PubMedPubMedCentral
22.
go back to reference Soroka SD, Granade TC, Candal D, Parekh BS. Modification of rapid human immunodeficiency virus (HIV) antibody assay protocols for detecting recent HIV seroconversion. Clin Diagn Lab Immunol. 2005;12:918–21.PubMedPubMedCentral Soroka SD, Granade TC, Candal D, Parekh BS. Modification of rapid human immunodeficiency virus (HIV) antibody assay protocols for detecting recent HIV seroconversion. Clin Diagn Lab Immunol. 2005;12:918–21.PubMedPubMedCentral
23.
go back to reference Aghokeng AF, Mpoudi-Ngole E, Dimodi H, Atem-Tambe A, Tongo M, Butel C, et al. Inaccurate diagnosis of HIV-1 group M and O is a key challenge for ongoing universal access to antiretroviral treatment and HIV prevention in Cameroon. PLoS One. 2009;4(11):e7702. doi:10.1371/journal.pone.0007702.CrossRefPubMedPubMedCentral Aghokeng AF, Mpoudi-Ngole E, Dimodi H, Atem-Tambe A, Tongo M, Butel C, et al. Inaccurate diagnosis of HIV-1 group M and O is a key challenge for ongoing universal access to antiretroviral treatment and HIV prevention in Cameroon. PLoS One. 2009;4(11):e7702. doi:10.1371/journal.pone.0007702.CrossRefPubMedPubMedCentral
Metadata
Title
Evaluation of HIV testing algorithms in Ethiopia: the role of the tie-breaker algorithm and weakly reacting test lines in contributing to a high rate of false positive HIV diagnoses
Authors
Leslie Shanks
M Ruby Siddiqui
Jarmila Kliescikova
Neil Pearce
Cono Ariti
Libsework Muluneh
Erwan Pirou
Koert Ritmeijer
Johnson Masiga
Almaz Abebe
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2015
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-015-0769-3

Other articles of this Issue 1/2015

BMC Infectious Diseases 1/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.